US "Best Practice" In Managed Care

16 December 1996

To improve managed care options and policies for Medicare and Medicaid beneficiaries, the Office of Managed Care at the US Health Care Financing Administration has conducted a study to identify some "best practices" of managed care organizations. It developed a model MCO which clustered activities into organizational and managerial, clinical and administrative activities, in which MCOs reported their best practices.

From this, the HCFA says it is particularly concerned about how MCOs plan to provide for the special needs of the very elderly, indigent and disabled, ie in planning and coordination of clinical and support services, health screenings and assessments, and outcomes measurement. For example, one MCO details a program to maintain seniors in their own homes as long as possible through care management and community-based services, providing substantial health education and prevention-oriented services. Using more long-term care services was found to use fewer high-cost services, and the program is conserving state funds. Without it, around 750 elderly people would go to nursing homes, with half of those in state-paid nursing homes, the study reported.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight